Navigation Links
YM BioSciences third quarter 2010 operational and financial results
Date:5/13/2010

clinical trials; that JAK 1/2 and the VDA molecule will generate positive efficacy and safety data in future clinical trials; AeroLEF(R) will continue to generate positive efficacy and safety data in future clinical trials; that and that YM and its various partners will complete their respective clinical trials within the timelines communicated in this release. Except as required by applicable securities laws, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

    YM BIOSCIENCES INC.
    Interim Consolidated Balance Sheets
    (Expressed in Canadian dollars, unless otherwise indicated)

    -------------------------------------------------------------------------
                                                    March 31,        June 30,
                                                        2010            2009
    -------------------------------------------------------------------------
                                                  (Unaudited)
    Assets

    Current assets:
      Cash                                      $  27,862,417  $   2,337,716
      Short-term deposits                          20,149,367     39,713,042
      Accounts receivable                             390,714        564,584
      Prepaid expenses                                129,589        352,850
      -----------------------------------------------------------------------
                                                   48,532,087     42,968,192

    Property and equipment                             95,794         96,876

    Intangible assets                              14,982,168      3,004,868

    -------------------------------------------------------------------------
                                                $  63,610,049  $  46,069,936
    -------------------------------------------------------------------------
    ---------------------------
'/>"/>
SOURCE  YM BioSciences Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 

Related biology technology :

1. Sangamo BioSciences Announces Presentation at Two Upcoming Investor Conferences
2. Regado Biosciences to Present at the BIO International Convention Held in Chicago, Illinois on May 5, 2010
3. YM BioSciences announces controlled equity offering
4. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2010 Financial Results
5. NeoStem, Inc. and ImmuneRegen BioSciences(R) Announce a Collaborative Agreement to Advance Stem Cell Technology
6. Neurocrine Biosciences, Inc. Announces Exercise of Over-Allotment Option for Common Stock Offering
7. YM BioSciences announces AACR acceptance of two nimotuzumab poster presentations
8. Neurocrine Biosciences to Present at the Roth 22nd Annual OC Growth Conference
9. YM BioSciences closes US$17.5 million financing
10. YM BioSciences to raise approximately US$15 million
11. Sangamo BioSciences Announces Presentation at Cowen and Company Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... MA (PRWEB) May 23, 2013 ... inch wide and provide 15 mm travel range ... The small dimensions make these new positioners ... confined spaces. A vacuum rated version is also ... Drawings, specifications and datasheets can be found at: ...
(Date:5/23/2013)... 2013 Virobay, Inc. today announced that their ... an important milestone, as Virobay has now initiated a ... cathepsin S inhibitor.   The first Phase ... study designed to evaluate the safety, tolerability, pharmacokinetics and ... "The initiation of this Phase 1 trial ...
(Date:5/23/2013)... May 23, 2013 Z Trim Holdings, Inc. ... to a variety of industries, announced that Chef ... discussion at this year,s National Restaurant Association ("NRA") NRA ... behalf of the Research Chefs Association.  Chef Ryan spoke ... Good, the Bad and the Ugly," joining four other ...
(Date:5/23/2013)... May 23, 2013 Pressure BioSciences, Inc. (OTCQB: ... Company will host a teleconference to discuss its First ... update. The teleconference information is provided below: ... Daylight Time (EDT) Dial-in: (800) 875-3456 (U.S.); ... (Int,l) Passcode: VS22823 For those unable to ...
Breaking Biology Technology:Precision Positioning System Uses Miniaturezed Piezo Linear Motor: LPS-24 Linear Stage by PI 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 3Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 2Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 3Pressure BioSciences, Inc. to Discuss First Quarter 2013 Financial Results and Provide Business Update 2
... Inc. (OTCBB: NRTI), announces the addition of Dr. David ...  Dr. Blecker, a graduate of Tufts University School of ... and is currently the Chief in Nephrology at AtlantiCare ... of Regional Nephrology Associates, a private practice located in ...
... May 1, 2012  SPYRU Inc., a privately held corporation, ... market of functional food & beverages. They,ve just announced ... – a revolutionary new line of high ... conscious adults and serious athletes alike, SPYru packs a ...
... American researchers have created a portable, miniature microscope in the hope ... probe, which is around 20 cm long and 1 cm wide ... cancer in real-time or as a surgical guidance tool; dentists could ... probe has been presented today, Friday 27 April, in IOP Publishing,s ...
Cached Biology Technology:Dr. David L. Blecker MD, MPH, F.A.C.P. Joins Inergetics' Advisory Board to Co-Develop and Market Products to Penetrate Nephrology Market 2Dr. David L. Blecker MD, MPH, F.A.C.P. Joins Inergetics' Advisory Board to Co-Develop and Market Products to Penetrate Nephrology Market 3SPYru™ unveils "The Uberwater" 2Handheld probe shows great promise for oral cancer detection 2
(Date:5/23/2013)... of the world are billions of animal and plant ... and grasses, all stacked, stored and preserved in jars ... could be critical to understanding how the Earth,s biodiversity ... footprint if only the information were easily accessible. ... the help of a team from the University of ...
(Date:5/23/2013)... in Neuron , the team reveal the interplay ... work funded by the Wellcome Trust and BBSRC. ... stimuli we improve our perceptual abilities. While these changes ... can also affect the fidelity of that response. ... Neuroscience explains: "When you communicate with others, you can ...
(Date:5/22/2013)... 2013 U.S. Forest Service scientists are part of ... from the TKF Foundation, will examine how collaborative planning ... recover from tragedy. , The TKF Foundation announced today ... selected for grant funding. In addition to research on ... recovery and resiliency, the 3-year, $585,000 grant will contribute ...
Breaking Biology News(10 mins):CU-Boulder helps tap crowds to digitize museum records of bugs and plants 2CU-Boulder helps tap crowds to digitize museum records of bugs and plants 3CU-Boulder helps tap crowds to digitize museum records of bugs and plants 4'Landscapes of Resilience' to study how people use nature as a source of recovery 2
... maxim: you are what you eat and, more to ... the brain. The findings offer insight into the neurobiological factors ... developed countries. The findings exposed changes in brain chemistry due ... 2009, the Society for Neuroscience,s annual meeting and the world,s ...
... Assistance in Area of National Need program has awarded ... to support a new graduate fellowship training program in ... next three years. An additional 25 percent match ... Biology and K-State,s office of research and sponsored programs, ...
... (Oct. 20, 2009) -- Rice University scientists have won ... Health to scrutinize the influenza A virus for clues ... of influenza A include this year,s pandemic H1N1 variety, ... Under the four-year program, biochemists in the laboratory ...
Cached Biology News:Think what you eat: Studies point to cellular factors linking diet and behavior 2K-State receives more than $780,000 to fund graduate students studying ecology, evolution, genomics 2Flu focus: NIH project aims for better drugs 2
... optically clear polystyrene formulation , High antibody-binding ... , Plates are certified for performance ... , Eight-well strips fit snugly in ... in use even if turned upside down ...
...
... an aqueous solution that contains a purified ... in a saline solution, pH 6.5 ... methylisothiazolone and 0.02% bromonitrodioxane as a preservative. ... and stabilizer for biologically active components in ...
... StabilGuard Biomolecule Stabilizer is a bovine protein-free ... is an aqueous solution that contains non-toxic ... saline), pH 6.6 - 7.2, and does ... maintains the activity of antibodies and other ...
Biology Products: